Dag Nyholm Selected Research

Deep Brain Stimulation

1/2021	Close relationships in Parkinson´s disease patients with device-aided therapy.
11/2013	Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dag Nyholm Research Topics

Disease

47	Parkinson Disease (Parkinson's Disease) 06/2022 - 03/2002
10	Dyskinesias (Dyskinesia) 01/2021 - 10/2006
3	Infections 01/2021 - 04/2009
2	Parkinsonian Disorders (Parkinsonism) 05/2022 - 01/2017
2	Huntington Disease (Huntington's Disease) 01/2021 - 11/2019
2	Torticollis (Wryneck) 09/2015 - 11/2012
1	Multiple System Atrophy 05/2022
1	Synucleinopathies 05/2022
1	Normal Pressure Hydrocephalus 02/2022
1	Helicobacter Infections 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Movement Disorders (Movement Disorder) 10/2017
1	Hypokinesia (Bradykinesia) 01/2014
1	Inflammation (Inflammations) 04/2009

Drug/Important Bio-Agent (IBA)

39	Levodopa (L Dopa)FDA LinkGeneric 06/2022 - 03/2002
25	Carbidopa (Lodosyn)FDA LinkGeneric 06/2022 - 10/2006
4	Pharmaceutical PreparationsIBA 01/2021 - 02/2008
4	Dopamine (Intropin)FDA LinkGeneric 10/2017 - 01/2006
3	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 01/2016 - 05/2003
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 02/2022
2	N- (3- iodoprop- 2- enyl)- 2- beta- carbomethoxy- 3- (4- methylphenyl)nortropaneIBA 05/2022 - 01/2017
2	entacapone (Comtan)FDA Link 01/2022 - 01/2017
2	SuspensionsIBA 03/2017 - 03/2008
2	abobotulinumtoxinA FDA Link 09/2015 - 11/2012
2	Type A Botulinum Toxins (Botox)FDA Link 09/2015 - 11/2012
2	Botulinum Toxins (Botulinum Toxin)IBA 09/2015 - 11/2012
1	SolutionsIBA 06/2022
1	SynucleinsIBA 05/2022
1	Apomorphine FDA Link 01/2021
1	proenkephalinIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 11/2019
1	Phenylalanine (L-Phenylalanine)FDA Link 11/2019
1	N- (3- fluorophenyl)- 1- ((4- (((3S)- 3- methyl- 1- piperazinyl)methyl)phenyl)acetyl)- 4- piperidinamineIBA 01/2018
1	mesdopetamIBA 01/2018
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2013
1	HomocysteineIBA 12/2013
1	3-methoxytyrosineIBA 04/2013
1	StalevoIBA 02/2011
1	TitaniumIBA 04/2009
1	Dopamine Receptors (Dopamine Receptor)IBA 10/2006
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2006
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2006
1	Carboxy-LyasesIBA 09/2004
1	Drug CombinationsIBA 03/2002

Therapy/Procedure

8	Therapeutics 02/2022 - 09/2004
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2006
2	Oral Administration 07/2021 - 03/2019
2	Deep Brain Stimulation 01/2021 - 11/2013
2	Activities of Daily Living (ADL) 09/2015 - 03/2002
1	Intravenous Infusions 06/2022
1	Precision Medicine 07/2021
1	Drug Tapering 01/2017
1	Aftercare (After-Treatment) 09/2015
1	Intramuscular Injections 09/2015
1	Gastrostomy 04/2009
1	Polypharmacy 01/2009